Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Kai, Yoshizawa"'
Autor:
Kentaro Matsuura, Noboru Hirashima, Etsuko Iio, Takeshi Matsui, Tomokatsu Miyaki, Hiroshi Abe, Yuichiro Eguchi, Susumu Tsutsumi, Katsuhiko Iwakiri, Tomonori Senoh, Norio Itokawa, Jong-Hon Kang, Noritomo Shimada, Koichi Takaguchi, Masanori Atsukawa, Kayoko Matsunami, Kai Yoshizawa, Keizo Kato, Atsunori Kusakabe, Kei Fujiwara, Yasuhito Tanaka, Hideyuki Nomura
Publikováno v:
Journal of Gastroenterology. 54:339-346
The aim of this study is to ascertain whether the TLL1 variant at rs17047200 is associated with the development of HCC after achieving sustained virological response (SVR) by interferon (IFN)-free therapy for chronic hepatitis C (CHC). A total of 102
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::121c023dc9d40992981e2193e82b7d9f
https://doi.org/10.1007/s00535-018-1526-3
https://doi.org/10.1007/s00535-018-1526-3
Autor:
Yoshio Aizawa, Hiroshi Abe, Akihito Tsubota, Noritomo Shimada, Masanori Atsukawa, Norio Itokawa, Tomomi Okubo, Taeang Arai, Ai Nakagawa, Chisa Kondo, Katsuhiko Iwakiri, Kai Yoshizawa
Publikováno v:
Hepatology Research. 47:641-649
AIM Although interferon-free therapy with direct-acting antivirals has developed as a standard of care for chronic hepatitis C, the existence of resistance-associated variants (RAVs) has a negative impact on treatment results. Recently, several studi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::09edb5ed980063c5540ec120e6c7bad6
https://doi.org/10.1111/hepr.12784
https://doi.org/10.1111/hepr.12784
Autor:
Kai Yoshizawa, Yasuhito Tanaka, Noboru Hirashima, Etsuko Iio, Noritomo Shimada, Tomoyuki Kuramitsu, Yuichiro Eguchi, Takeshi Matsui, Hideyuki Nomura, Jong-Hon Kang, Noboru Shinkai, Tomokatsu Miyaki, Akihito Tsubota, Izumi Hasegawa, Shunsuke Nojiri, Koichi Takaguchi, Masanori Atsukawa, Kei Fujiwara, Hiroshi Abe, Atsunori Kusakabe
Publikováno v:
Journal of Gastroenterology. 52:94-103
The present study explored the treatment outcome of daclatasvir (DCV) and asunaprevir (ASV) therapy combining oral direct-acting antiviral agents (DAAs) for chronic hepatitis C (HCV) including liver cirrhosis according to resistance-associated varian
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe4b415fbd7945f59311921b0b344ae1
https://doi.org/10.1007/s00535-016-1225-x
https://doi.org/10.1007/s00535-016-1225-x
Autor:
Atsushi Nakajima, Izumi Tsuchiya, Motoyoshi Izumi, Kanji Ohkuma, Yoshifumi Masui, Kai Yoshizawa, Emiko Tanida, Shingo Kato, Leo Taniguchi, Eri Uchida
Publikováno v:
Arab journal of gastroenterology : the official publication of the Pan-Arab Association of Gastroenterology. 21(3)
Background and study aims Endoscopic submucosal dissection (ESD) is widely used as a treatment modality for gastric mucosal neoplasia. While proton pump inhibitors (PPIs) have been used for the control of artificial ulcers created by ESD (ESD-ulcers)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::327ffb45a3e61c2393ff3e960d6babee
https://pubmed.ncbi.nlm.nih.gov/32798188
https://pubmed.ncbi.nlm.nih.gov/32798188
Autor:
Yasushi Matsuzaki, Yuji Osada, Tomomi Okubo, Masahiro Araki, Hiroshi Abe, Katsuhisa Nakatsuka, Yoshimichi Chuganji, Toru Asano, Yoshio Aizawa, Chisa Kondo, Masanori Atsukawa, Katsuhiko Iwakiri, Akihito Tsubota, Kai Yoshizawa, Yusuke Ohkubo, Tadashi Ikegami, Noritomo Shimada
Publikováno v:
Hepatology Research. 46:450-458
Aim Protease inhibitors with pegylated interferon (PEG IFN)/ribavirin improve a sustained virological response (SVR) rate to approximately 90% in chronic hepatitis C genotype 1b patients with IL28B rs8099917 genotype TT, but yield only approximately
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::64920c59d2537ed5cc1b25d4985d7748
https://doi.org/10.1111/hepr.12575
https://doi.org/10.1111/hepr.12575
Autor:
Choitsu Sakamoto, Tatsuya Ide, Makiko Ika, Takashi Kumada, Noritomo Shimada, Kai Yoshizawa, Yoshiyuki Sato, Hiroshi Abe, Yoshimichi Chuganji, Keizo Kato, Koichi Takaguchi, Masanori Atsukawa, Yoshio Aizawa, Akihito Tsubota, Hidenori Toyoda, Michio Sata
Publikováno v:
Hepatology Research. 44:E386-E396
Aim The sustained virological response (SVR) rate of non-responders to peginterferon and ribavirin therapy (PR) is low for 24-week telaprevir-based triple combination therapy (T12PR24), compared to that of treatment-naive patients or previous-treatme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e6c806c11ba940921cc0f06db2928f3
https://doi.org/10.1111/hepr.12323
https://doi.org/10.1111/hepr.12323
Autor:
Yoshio Aizawa, Nobuyoshi Seki, Haruya Ishiguro, Yuta Aida, Tomonori Sugita, Hiroto Furuhashi, Satoshi Sutoh, Kai Yoshizawa, Munenori Itagaki, Yukiko Miura, Yuki Hirose, Tamihiro Miyazaki, Hiroshi Abe
Publikováno v:
Clinical Journal of Gastroenterology. 7:68-73
Tuberculous lymphadenitis is a rare cause of obstructive jaundice. Here, we report the case of a 33-year-old male with obstructive jaundice caused by tuberculous lymphadenitis around the pancreatic head. The patient was born in China and had immigrat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9c4a167ca9e6c38e4710b84f3b1e4516
https://doi.org/10.1007/s12328-013-0451-5
https://doi.org/10.1007/s12328-013-0451-5
Autor:
Emiko Tanida, Eri Uchida, Akihisa Hidaka, Masaaki Noguchi, Motoyoshi Izumi, Kai Yoshizawa, Izumi Tsuchiya, Eri Hayashi, Takahiro Abe, Akira Kanezaki, Zensho Ito, Tsuyoshi Abe, Tomohisa Nagano, Kanji Okuma, Keigo Shirahama, Yoshifumi Masui
Publikováno v:
Progress of Digestive Endoscopy. 84:43-47
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::222ac112ecb3a8ec2c72350dac529392
https://doi.org/10.11641/pde.84.1_43
https://doi.org/10.11641/pde.84.1_43
Autor:
Hisao Tajiri, Yukinaga Yoshida, Kazuki Sumiyama, Kai Yoshizawa, Yosuke Kawahara, Haruya Ishiguro, Koji Matsuda
Publikováno v:
International Journal of Colorectal Disease. 28:1511-1516
Narrow band imaging (NBI) and flexible spectral imaging color enhancement (FICE) allow improved contrasted evaluation of the mucosal surface. However, no study has compared the utility of these two modalities. Therefore, the aim of this study was to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d906924a742b2455dc7e2eb6c22d313
https://doi.org/10.1007/s00384-013-1735-4
https://doi.org/10.1007/s00384-013-1735-4
Autor:
Satoshi Sutoh, Kai Yoshizawa, Akihito Tsubota, Tamihiro Miyazaki, Makiko Ika, Nobuyoshi Seki, Hiroshi Abe, Noritomo Shimada, Yuta Aida, Munenori Itagaki, Yoshio Aizawa, Haruya Ishiguro, Keizo Kato
Publikováno v:
Journal of Medical Virology. 85:1523-1533
This study aimed to determine the most suitable duration of pegylated-interferon (Peg-IFN)-plus-ribavirin combination therapy in patients infected with hepatitis C virus (HCV) genotype 2 who had not achieved rapid virological response (serum HCV RNA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1a8aef75f7a2a48dcff290a20dbc16fc
https://doi.org/10.1002/jmv.23626
https://doi.org/10.1002/jmv.23626